Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
S&P Global Ratings Upgrades Teva to ‘BB+’ Amid Strong Execution of Pivot to Growth Strategy; Moody’s Ratings Agency Revises Outlook to Positive
PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements
MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings
Project discussion at Charité The founder of aiomics speaking about the implementation assessment with Professor Akira Sebastian-Poncette and MD student...
LA JOLLA, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market...
VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) a...
Syngenta and Amoeba SA to develop and commercialize biocontrol solutions for EU and UKChassieu, France Basel, Switzerland , Nov. 18,...
Syngenta e Amoéba SA vão desenvolver e comercializar soluções de biocontrolo na UE e no Reino UnidoBasileia, Suíça Chassieu, França,...
PRESS RELEASE New operating system enables scientists to move from copilot to autopilot, unifying diverse in silico, wet lab research...
VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of...
Strategy will combine internal innovation, licensing, and strategic acquisitions to drive sustainable value creation for shareholdersStrategic initiative follows positive topline...
At interim analysis, giredestrant demonstrated a statistically significant and clinically meaningful benefit versus standard-of-care endocrine monotherapyThese unprecedented results support its...
FOSTER CITY, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a California-based late-stage...
NEW HAVEN, Conn., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Invivyd) (Nasdaq: IVVD) today announced the pricing of an...
Artisan and Tulex Report Positive Phase 2a Results for Autism Drug ART-501SAN DIEGO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Artisan...
Vancouver, British Columbia--(Newsfile Corp. - November 18, 2025) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company")...
Strategic partnership to develop advanced formulations of eco-friendly pathogen-elimination agents and expand FendX's hygiene solutions portfolioVancouver, British Columbia--(Newsfile Corp. -...
Proprietary acoustic sleep harmonization technology delivers tailored sound and vibration patterns based on each user’s unique craniofacial anatomy.SAN FRANCISCO--(BUSINESS WIRE)--SoundHealth,...
Proprietary acoustic sleep harmonization technology delivers tailored sound and vibration patterns based on each user’s unique craniofacial anatomy.SAN FRANCISCO--(BUSINESS WIRE)--SoundHealth,...
BALTIMORE--(BUSINESS WIRE)--CoapTech, a medical technology company advancing ultrasound‑guided solutions for enteral access, today announced that its Board of Directors has...
HYDERABAD, India, Nov. 18, 2025 /PRNewswire/ -- According to Mordor Intelligence, the global biosensors market is valued at USD 28.50 billion in 2025...
Certification opens the United Kingdom market for the first FDA-cleared AI platform for prostate MRI interpretation. OMAHA, Neb., Nov. 18,...
OXFORD, England, Nov. 18, 2025 /PRNewswire/ -- Ochre Bio, a biotechnology company developing RNA therapeutics for chronic liver disease, today...
